ReviewNeurourology and urodynamics2026
Seventy-Five Years of NIH NIDDK Funding Has Increased Knowledge and Greatly Impacted Clinical Care.
Review in Neurourology and urodynamics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Seventy-five years of research funding in benign Urology from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health has greatly advanced not only our knowledge of etiology and mechanisms of nononcologic urological conditions but has also advanced new technologies and treatments to improve clinical care. To illustrate the profound impact of NIDDK funding on research and clinical care, we undertook a survey of grants funded by NIDDK in the NIH Reporter website with a focus on translation of lower urinary tract health and disease research to the clinic. We highlight three examples of technologies whose development was funded by NIDDK: advanced artificial urinary sphincters, urodynamics, and neuromodulation. These examples demonstrate the difficulties in bringing innovations to clinical care, as well as successes. In addition, they illustrate how public investment through NIDDK funding can improve treatment outcomes, diagnostic capabilities, and provide multiple therapeutic options.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.